TPL also suppressed NRF2/SLC7A11 axis and induced ROS accumulation in cancer cells, thus synergized with erastin to kill head and neck cancer cells, regardless of the expression status of GSDME (Fig. 9). This evidence concerns the gene GSDME and head and neck cancer.